Jusvinza treatment resolution in confirmed COVID-19 patients. Santiago de Cuba, 2021
<strong>Foundation</strong>: SARS-CoV-2 infection is the most important emerging disease of this century. In this context, the Cuban Biotechnology and Pharmaceutical Industries Group (BioCubaFarma) created therapeutic alternatives to combat COVID-19, including the use of Jusvinza, which...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |